Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

Demographic buffering: titrating the effects of birth rate and imperfect immunity on epidemic dynamics.

Morris SE, Pitzer VE, Viboud C, Metcalf CJ, Bjørnstad ON, Grenfell BT.

J R Soc Interface. 2015 Mar 6;12(104):20141245. doi: 10.1098/rsif.2014.1245.

2.

Disease caused by rotavirus infection.

Lin CL, Chen SC, Liu SY, Chen KT.

Open Virol J. 2014 Dec 11;8:14-9. doi: 10.2174/1874357901408010014. eCollection 2014.

3.

Human milk contains novel glycans that are potential decoy receptors for neonatal rotaviruses.

Yu Y, Lasanajak Y, Song X, Hu L, Ramani S, Mickum ML, Ashline DJ, Prasad BV, Estes MK, Reinhold VN, Cummings RD, Smith DF.

Mol Cell Proteomics. 2014 Nov;13(11):2944-60. doi: 10.1074/mcp.M114.039875. Epub 2014 Jul 21.

4.

Rotarix in Japan: Expectations and Concerns.

Nakagomi O, Nakagomi T.

Biol Ther. 2011 Dec 14;1:4. eCollection 2011. Review.

5.

Does a monovalent inactivated human rotavirus vaccine induce heterotypic immunity? Evidence from animal studies.

Jiang B, Wang Y, Glass RI.

Hum Vaccin Immunother. 2013 Aug;9(8):1634-7. doi: 10.4161/hv.24958. Epub 2013 Jun 6.

6.

Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in developed countries.

Plosker GL.

Drugs R D. 2012 Dec 1;12(4):239-44. doi: 10.2165/11208130-000000000-00000.

7.

Protective effect of natural rotavirus infection in an Indian birth cohort.

Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, Jaffar S, Gomara MI, Gray JJ, Brown DW, Desselberger U, Crawford SE, John J, Babji S, Estes MK, Kang G.

N Engl J Med. 2011 Jul 28;365(4):337-46. doi: 10.1056/NEJMoa1006261.

8.
9.

Performance of rotavirus vaccines in developed and developing countries.

Jiang V, Jiang B, Tate J, Parashar UD, Patel MM.

Hum Vaccin. 2010 Jul;6(7):532-42. Review.

10.

Complete genome sequence analysis of candidate human rotavirus vaccine strains RV3 and 116E.

Rippinger CM, Patton JT, McDonald SM.

Virology. 2010 Sep 15;405(1):201-13. doi: 10.1016/j.virol.2010.06.005. Epub 2010 Jun 26.

11.

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency.

Patel NC, Hertel PM, Estes MK, de la Morena M, Petru AM, Noroski LM, Revell PA, Hanson IC, Paul ME, Rosenblatt HM, Abramson SL.

N Engl J Med. 2010 Jan 28;362(4):314-9. doi: 10.1056/NEJMoa0904485.

12.

Non-structural protein NSP2 induces heterotypic antibody responses during primary rotavirus infection and reinfection in children.

Kirkwood CD, Boniface K, Richardson S, Taraporewala ZF, Patton JT, Bishop RF.

J Med Virol. 2008 Jun;80(6):1090-8. doi: 10.1002/jmv.21160.

13.

Rotavirus vaccines: an overview.

Dennehy PH.

Clin Microbiol Rev. 2008 Jan;21(1):198-208. doi: 10.1128/CMR.00029-07. Review.

14.

First detection of G12 rotaviruses in newborns with neonatal rotavirus infection at all India Institute of Medical Sciences, New Delhi, India.

Ray P, Sharma S, Agarwal RK, Longmei K, Gentsch JR, Paul VK, Glass RI, Bhan MK.

J Clin Microbiol. 2007 Nov;45(11):3824-7. Epub 2007 Aug 29.

15.

Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India.

Banerjee I, Gladstone BP, Le Fevre AM, Ramani S, Iturriza-Gomara M, Gray JJ, Brown DW, Estes MK, Muliyil JP, Jaffar S, Kang G.

J Infect Dis. 2007 Mar 1;195(5):625-32. Epub 2007 Jan 22.

16.

Rotavirus vaccines.

Kang G.

Indian J Med Microbiol. 2006 Oct;24(4):252-7. Review.

17.

Mice develop effective but delayed protective immune responses when immunized as neonates either intranasally with nonliving VP6/LT(R192G) or orally with live rhesus rotavirus vaccine candidates.

VanCott JL, Prada AE, McNeal MM, Stone SC, Basu M, Huffer B Jr, Smiley KL, Shao M, Bean JA, Clements JD, Choi AH, Ward RL.

J Virol. 2006 May;80(10):4949-61.

18.

Serum IgG mediates mucosal immunity against rotavirus infection.

Westerman LE, McClure HM, Jiang B, Almond JW, Glass RI.

Proc Natl Acad Sci U S A. 2005 May 17;102(20):7268-73. Epub 2005 May 9.

19.

Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection.

Xu J, Dennehy P, Keyserling H, Westerman LE, Wang Y, Holman RC, Gentsch JR, Glass RI, Jiang B.

Clin Diagn Lab Immunol. 2005 Feb;12(2):273-9.

Items per page

Supplemental Content

Write to the Help Desk